Cargando…

PD-L1/PD-1 and CTLA-4 Expression in Equine Penile Squamous Cell Carcinomas

SIMPLE SUMMARY: In the last few years, the treatment of different types of tumors in humans has benefited from the introduction of new drugs called “immune checkpoint inhibitors” (ICI). These treatments help the patient’s immune response in fighting against cancer, therefore limiting tumor growth an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Porcellato, Ilaria, Mecocci, Samanta, Brachelente, Chiara, Cappelli, Katia, Armando, Federico, Tognoloni, Alessia, Chiaradia, Elisabetta, Stefanetti, Valentina, Mechelli, Luca, Pepe, Marco, Gialletti, Rodolfo, Passeri, Benedetta, Ghelardi, Alessandro, Razzuoli, Elisabetta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8300259/ https://www.ncbi.nlm.nih.gov/pubmed/34359249 http://dx.doi.org/10.3390/ani11072121

Ejemplares similares

Investigation of the Epithelial to Mesenchymal Transition (EMT) Process in Equine Papillomavirus-2 (EcPV-2)-Positive Penile Squamous Cell Carcinomas
por: Armando, Federico, et al.
Publicado: (2021)

Equine Penile Squamous Cell Carcinomas as a Model for Human Disease: A Preliminary Investigation on Tumor Immune Microenvironment
por: Porcellato, Ilaria, et al.
Publicado: (2020)

Equine Genital Squamous Cell Carcinoma Associated with EcPV2 Infection: RANKL Pathway Correlated to Inflammation and Wnt Signaling Activation
por: Mecocci, Samanta, et al.
Publicado: (2021)

Circulating Transcriptional Profile Modulation in Response to Metabolic Unbalance Due to Long-Term Exercise in Equine Athletes: A Pilot Study
por: Cappelli, Katia, et al.
Publicado: (2021)

Tumor-Associated Macrophages in Canine Oral and Cutaneous Melanomas and Melanocytomas: Phenotypic and Prognostic Assessment
por: Porcellato, Ilaria, et al.
Publicado: (2022)

Detection of Equus Caballus Papillomavirus Type-2 in Asymptomatic Italian Horses
por: Cappelli, Katia, et al.
Publicado: (2022)

Characterization of Primary Cultures of Normal and Neoplastic Canine Melanocytes
por: Sforna, Monica, et al.
Publicado: (2021)

Antimicrobial and Immunomodulatory Potential of Cow Colostrum Extracellular Vesicles (ColosEVs) in an Intestinal In Vitro Model
por: Mecocci, Samanta, et al.
Publicado: (2022)

Immune Response in Young Thoroughbred Racehorses under Training
por: Cappelli, Katia, et al.
Publicado: (2020)

Equine Adipose-Derived Mesenchymal Stromal Cells Release Extracellular Vesicles Enclosing Different Subsets of Small RNAs
por: Capomaccio, Stefano, et al.
Publicado: (2019)

Genetic Characterization of a Novel Equus caballus Papillomavirus Isolated from a Thoroughbred Mare
por: Turco, Silvia, et al.
Publicado: (2023)

Platelets Rich Plasma Increases Antioxidant Defenses of Tenocytes via Nrf2 Signal Pathway
por: Tognoloni, Alessia, et al.
Publicado: (2023)

Bovine Papillomavirus Type 1 Infection in an Equine Congenital Papilloma
por: Maggi, Raffaella, et al.
Publicado: (2023)

Toll-like Receptors and Cytokine Modulation by Goat Milk Extracellular Vesicles in a Model of Intestinal Inflammation
por: De Ciucis, Chiara Grazia, et al.
Publicado: (2023)

Transcriptome Analysis of Canine Cutaneous Melanoma and Melanocytoma Reveals a Modulation of Genes Regulating Extracellular Matrix Metabolism and Cell Cycle
por: Brachelente, Chiara, et al.
Publicado: (2017)

Cow Milk Extracellular Vesicle Effects on an In Vitro Model of Intestinal Inflammation
por: Mecocci, Samanta, et al.
Publicado: (2022)

Goat milk extracellular vesicles: immuno-modulation effects on porcine monocyte-derived macrophages in vitro
por: Franzoni, Giulia, et al.
Publicado: (2023)

Corrigendum: Goat milk extracellular vesicles: immuno-modulation effects on porcine monocyte-derived macrophages in vitro
por: Franzoni, Giulia, et al.
Publicado: (2023)

High Expression of Endogenous Retroviral Envelope Gene in the Equine Fetal Part of the Placenta
por: Stefanetti, Valentina, et al.
Publicado: (2016)

A Retrospective Investigation on Canine Papillomavirus 1 (CPV1) in Oral Oncogenesis Reveals Dogs Are Not a Suitable Animal Model for High-Risk HPV-Induced Oral Cancer
por: Porcellato, Ilaria, et al.
Publicado: (2014)

Proteome Alterations in Equine Osteochondrotic Chondrocytes
por: Chiaradia, Elisabetta, et al.
Publicado: (2019)

Extracellular Vesicles from Animal Milk: Great Potentialities and Critical Issues
por: Mecocci, Samanta, et al.
Publicado: (2022)

CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma
por: Guo, Xiao-Jun, et al.
Publicado: (2021)

ODP342 Panhypopituitarism Induced by CTLA-4 and PD-1/PD-L1 Inhibitor Immunotherapy
por: Hernandez-Cordero, Nicole, et al.
Publicado: (2022)

CTLA-4 and PD-1 Pathway Blockade: Combinations in the Clinic
por: Callahan, Margaret K., et al.
Publicado: (2015)

Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy
por: Heinzerling, Lucie, et al.
Publicado: (2016)

Combination of CTLA-4 and PD-1 blockers for treatment of cancer
por: Rotte, Anand
Publicado: (2019)

Inborn Errors of Immunity and Their Phenocopies: CTLA4 and PD-1
por: Hao, Yuwei, et al.
Publicado: (2022)

Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents
por: Yang, Hui, et al.
Publicado: (2013)

Evaluation of β-Lactamase Enzyme Activity in Outer Membrane Vesicles (OMVs) Isolated from Extended Spectrum β-Lactamase (ESBL) Salmonella Infantis Strains
por: Toppi, Valeria, et al.
Publicado: (2023)

Equus caballus Papillomavirus Type-9 (EcPV9): First Detection in Asymptomatic Italian Horses
por: De Paolis, Livia, et al.
Publicado: (2022)

Exploiting CTLA-4, PD-1 and PD-L1 to reactivate the host immune response against cancer
por: Quezada, S A, et al.
Publicado: (2013)

Molecular Interactions of Antibody Drugs Targeting PD-1, PD-L1, and CTLA-4 in Immuno-Oncology
por: Lee, Hyun Tae, et al.
Publicado: (2019)

SARS-CoV-2 infection: The role of PD-1/PD-L1 and CTLA-4 axis
por: Aghbash, Parisa Shiri, et al.
Publicado: (2021)

Meta-Analysis of Efficacy From CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients
por: Xu, Li, et al.
Publicado: (2022)

CTLA-4 and PD-1 Pathways: Similarities, Differences, and Implications of Their Inhibition
por: Buchbinder, Elizabeth I., et al.
Publicado: (2016)

Expression of PD‐L1 and CTLA‐4 in female urethral carcinoma
por: Ninomiya, Sahoko, et al.
Publicado: (2018)

Immune Monitoring of Cancer Patients Prior to and During CTLA-4 or PD-1/PD-L1 Inhibitor Treatment
por: Tunger, Antje, et al.
Publicado: (2018)

Revolutionization in Cancer Therapeutics via Targeting Major Immune Checkpoints PD-1, PD-L1 and CTLA-4
por: Pandey, Pratibha, et al.
Publicado: (2022)

Differential Expression Pattern of Retroviral Envelope Gene in the Equine Placenta
por: Stefanetti, Valentina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hdm6osn5to5r9vh8u0h850hdpa